ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's Net Worth
$177 Million
Who is ESSEX WOODLANDS HEALTH VENTURES FUND VII LP?
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP has an estimated net worth of $177 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., Corium International, Inc., ENDOLOGIX INC /DE/, ORTHOVITA INC, and LA JOLLA PHARMACEUTICAL CO.
SEC CIK
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's CIK is 0001367998
Past Insider Trading and Trends
2008 was ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's most active year for acquiring shares with 16 total transactions. ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's most active month to acquire stocks was the month of September. 2014 was ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's most active year for disposing of shares, totalling 11 transactions. ESSEX WOODLANDS HEALTH VENTURES FUND VII LP's most active month to dispose stocks was the month of March. 2008 saw ESSEX WOODLANDS HEALTH VENTURES FUND VII LP paying a total of $15,366,560.83 for 9,922,711 shares, this is the most they've acquired in one year. In 2018 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP cashed out on 9,353,304 shares for a total of $116,916,300.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HORIZON PHARMA, INC. No price found
InvestorESSEX WOODLANDS HEALTH VENTURES FUND VII LP owns 5,064,731 units of Common Stock. In the year 2011 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +119.89% | 2.76M |
$3.59 | $9,913,702.43 | 5.06M |
Mar 2
| |||
Form 4
|
∞
| 2.3M |
$9.00 |
—
| 2.3M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Corium International, Inc. No price found
InvestorESSEX WOODLANDS HEALTH VENTURES FUND VII LP used to own units in Common Stock but no longer holds any shares there. In the year 2014 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.35M |
$12.50 | -$116,916,300.00 |
0
|
Nov 27
| |||
Form 4
| +276.44% | 9.35M |
$8.00 |
—
| 12.74M |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ENDOLOGIX INC /DE/ No price found
InvestorESSEX WOODLANDS HEALTH VENTURES FUND VII LP owns 1,165,428 units of Common Stock. In the year 2012 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -51.75% | -1.25M |
$13.17 | -$16,461,750.00 | 1.17M |
Nov 1
| |||
Form 4
| -17.33% | -461.89K |
$12.14 | -$5,609,539.76 | 2.2M |
Sep 10 - Sep 11
| |||
Form 4
| -36.59% | -1.54M |
$12.14 | -$18,672,631.12 | 2.67M |
Sep 6
| |||
Form 4
| -22.92% | -1.25M |
$12.87 | -$16,087,786.37 | 4.2M |
Feb 27 - Feb 28
| |||
No matching records found |
ORTHOVITA INC No price found
InvestorESSEX WOODLANDS HEALTH VENTURES FUND VII LP used to own units in Common Stock but no longer holds any shares there. In the year 2007 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP acquired a total of 163,442 shares in ORTHOVITA INC at a cost of $366,564.73, ESSEX also disposed a total of 9,633,139 shares of ORTHOVITA INC equalling to $37,087,585.15.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.63M |
$3.85 | -$37,087,585.15 |
0
|
Jun 27
| |||
Form 4
| +0.12% | 11.37K |
$2.37 | $26,993.72 | 9.63M |
Nov 20
| |||
Form 4
| +0.02% | 1.5K |
$2.28 | $3,415.95 | 9.62M |
Oct 28
| |||
Form 4
| +0.25% | 23.9K |
$2.25 | $53,752.58 | 9.62M |
Oct 24 - Oct 27
| |||
Form 4
| +0.03% | 2.5K |
$2.28 | $5,700.00 | 9.6M |
Oct 22
| |||
Form 4
| +0.14% | 13.8K |
$2.25 | $31,116.24 | 9.59M |
Oct 16
| |||
Form 4
| +0.43% | 40.67K |
$2.09 | $85,061.39 | 9.58M |
Oct 10 - Oct 13
| |||
Form 4
| +0.37% | 35K |
$2.26 | $79,233.00 | 9.54M |
Oct 8 - Oct 9
| |||
Form 4
| +0.37% | 34.7K |
$2.34 | $81,291.85 | 9.5M |
Oct 2 - Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
LA JOLLA PHARMACEUTICAL CO No price found
InvestorESSEX WOODLANDS HEALTH VENTURES FUND VII LP used to own units in Common Stock but no longer holds any shares there.acquired a total of 7,807,415 shares in LA JOLLA PHARMACEUTICAL CO at a cost of $14,756,014.35, ESSEX also disposed a total of 7,807,415 shares of LA JOLLA PHARMACEUTICAL CO equalling to $603,333.98.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.06M |
$0.19 | -$196,841.26 |
0
|
Aug 5 - Aug 6
| |||
Form 4
| -86.42% | -6.75M |
$0.06 | -$406,492.70 | 1.06M |
Feb 24 - Feb 26
| |||
Form 4
|
∞
| 7.81M |
$1.89 | $14,756,014.35 | 7.81M |
May 12
| |||
No matching records found |